|
MED1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.66419999956003E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.88799999999434E-05 |
| Normal-vs-Stage2 |
3.518800E-03 |
| Normal-vs-Stage3 |
8.08449999945005E-07 |
| Normal-vs-Stage4 |
2.58890000548462E-08 |
| Stage1-vs-Stage2 |
5.443600E-01 |
| Stage1-vs-Stage3 |
2.825800E-01 |
| Stage1-vs-Stage4 |
2.529800E-02 |
| Stage2-vs-Stage3 |
1.912780E-01 |
| Stage2-vs-Stage4 |
3.869800E-02 |
| Stage3-vs-Stage4 |
2.831000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.37800000041966E-07 |
| Normal-vs-AfricanAmerican |
1.557680E-02 |
| Normal-vs-Asian |
1.952440E-04 |
| Caucasian-vs-AfricanAmerican |
4.129000E-01 |
| Caucasian-vs-Asian |
9.789400E-01 |
| AfricanAmerican-vs-Asian |
4.738600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.49319999978681E-07 |
| Normal-vs-Female |
2.76619999994843E-06 |
| Male-vs-Female |
1.861620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.642190E-04 |
| Normal-vs-Age(41-60Yrs) |
2.55899999968001E-07 |
| Normal-vs-Age(61-80Yrs) |
1.45470000001424E-06 |
| Normal-vs-Age(81-100Yrs) |
1.047890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.497840E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.368000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.625000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.769200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.875600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.919800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.359840E-01 |
| Classical-VS-Follicular |
2.767600E-02 |
| Classical-VS-Other |
4.852400E-02 |
| Classical-VS-Normal |
4.47940000000147E-05 |
| Tall-VS-Follicular |
9.906800E-01 |
| Tall-VS-Other |
2.305800E-01 |
| Tall-VS-Normal |
6.19450000000077E-05 |
| Follicular-VS-Other |
2.989400E-01 |
| Follicular-VS-Normal |
3.05560000002369E-06 |
| Other-VS-Normal |
6.231500E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.58070000003219E-06 |
| Normal-vs-N1 |
9.78490000025367E-07 |
| N0-vs-N1 |
2.276800E-01 |
|
|
